Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.933 |
15 |
1
|
1998 |
2018 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.460 |
None |
1.000 |
6 |
|
1997 |
2018 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.360 |
None |
1.000 |
6 |
|
1997 |
2018 |
Barrett Esophagus
|
disease |
Digestive System Diseases; Neoplasms
|
Disease or Syndrome
|
478
|
60
|
0.050 |
None |
1.000 |
5 |
|
2010 |
2017 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.040 |
None |
0.750 |
4 |
|
2011 |
2014 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.030 |
None |
1.000 |
3 |
|
1999 |
2016 |
Childhood Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2527
|
98
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Adult Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2528
|
98
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.320 |
None |
1.000 |
2 |
|
2006 |
2011 |
Bilirubin measurement
|
phenotype |
|
Laboratory Procedure
|
56
|
535
|
0.100 |
None |
1.000 |
2 |
2
|
2009 |
2018 |
Childhood Kidney Wilms Tumor
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
338
|
36
|
0.020 |
None |
1.000 |
2 |
1
|
1998 |
1998 |
Nephroblastoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
586
|
125
|
0.020 |
None |
1.000 |
2 |
1
|
1998 |
1998 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
1998 |
2013 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2015 |
Hepatoblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
452
|
22
|
0.020 |
None |
1.000 |
2 |
|
1998 |
2004 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2011 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.600 |
None |
1.000 |
1 |
1
|
1998 |
1998 |
Embryonal Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
121
|
8
|
0.400 |
None |
1.000 |
1 |
|
1998 |
1998 |
Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
565
|
20
|
0.310 |
None |
1.000 |
1 |
|
1998 |
1998 |
Alcoholic Intoxication, Chronic
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
577
|
441
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Bilirubin level result
|
phenotype |
|
Laboratory or Test Result
|
32
|
478
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Primary adenocarcinoma of lower third of esophagus due to Barrett esophagus
|
disease |
|
Neoplastic Process
|
31
|
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |